Carlos Bonilla, Author at CereVasc | Neurological Disease Device Company

About Carlos Bonilla

This author has not yet filled in any details.
So far Carlos Bonilla has created 13 blog entries.

04 Mar, 2026

First-in-Human Use of CereVasc® eShunt® System in Idiopathic Intracranial Hypertension Demonstrates Sustained Clinical Outcomes

Carlos Bonilla2026-03-03T23:11:02+00:00March 4th, 2026|

24 Feb, 2026

CereVasc, Inc. Announces Publication of a Multi-Center Study Evaluating the eShunt® System in the Treatment of Patients with NPH

Carlos Bonilla2026-02-24T14:26:49+00:00February 24th, 2026|

31 Mar, 2025

Morphometric analysis of the inferior petrosal sinus and cerebellopontine angle cistern to assess feasibility of endovascular shunting in pediatric patients

Carlos Bonilla2025-08-06T21:08:18+00:00March 31st, 2025|Tags: Journal of NeuroInterventional Surgery|

26 Mar, 2025

A paradigm shift in hydrocephalus management: the promise of endovascular cerebrospinal fluid diversion

Carlos Bonilla2025-08-06T21:05:37+00:00March 26th, 2025|Tags: Cardiology in Review|

25 Feb, 2025

CereVasc Announces First Patient Randomized to eShunt® System Treatment in STRIDE Pivotal Trial

Carlos Bonilla2025-07-19T20:00:14+00:00February 25th, 2025|

13 Feb, 2025

CereVasc Receives Approval for STRIDE Clinical Trial of the eShunt® System for the Treatment of Elderly Patients with Normal Pressure Hydrocephalus in Argentina

Carlos Bonilla2025-07-19T20:08:17+00:00February 13th, 2025|

05 Feb, 2025

CereVasc, Inc. Announces Results of Groundbreaking Clinical Study of the eShunt® System in the Treatment of Elderly Patients with Normal Pressure Hydrocephalus

Carlos Bonilla2025-07-19T20:10:54+00:00February 5th, 2025|

14 Jan, 2025

CereVasc Announces First Enrollment in STRIDE Clinical Trial of the eShunt® System for Normal Pressure Hydrocephalus

Carlos Bonilla2025-07-19T19:59:04+00:00January 14th, 2025|

25 Nov, 2024

CereVasc to Present at the Piper Sandler 36th Annual Healthcare Conference

Carlos Bonilla2025-05-20T21:01:09+00:00November 25th, 2024|

25 Sep, 2024

CereVasc Announces Journal of Molecular Therapy Publication Highlighting the eShunt® Platform as a CNS Gene Therapy Delivery Method

Carlos Bonilla2026-01-28T18:14:55+00:00September 25th, 2024|